Long Island University is one of five universities participating in a wide-ranging research project with The U.S. Food and Drug Administration (FDA). The project awards $1.7 million to the five universities. Once completed, the research will help the FDA better understand how to employ its quality management resources when inspecting drug companies’ manufacturing operations. LIU’s primary role is to provide manufacturing plants with pharmaceutical product and regulatory expertise. This ensures that product characteristics contributing to potential risk are identified and included in overall assessed risk. The project will benefit consumers and yield invaluable ancillary findings.
